Cognitive dysfunction is one of the leading causes of disability in multiple scelerosis (MS), exacting a tremendous socioeconomic and interpersonal toll. Unfortunately, previous attempts to rehabilitate cognitive dysfunction in MS have had only limited success. The investigators intend to overcome the limitations of previous studies by: 1) testing the efficacy of interventions that specifically target cognitive functioning; and 2) utilizing a novel outcome measurement that may be more sensitive and ecologically valid for the cognitive dysfunction that occurs in MS. The proposed experiments will determine the efficacy of donepezil therapy and glucose administration for enhancing memory functioning in individuals with MS. The investigators will also measure secondary outcomes assessing other areas of cognitive dysfunction (i.e., nonverbal memory, conceptual thinking, processing speed) which may improve with intervention.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD038107-03
Application #
6388168
Study Section
Behavioral Medicine Study Section (BEM)
Program Officer
Ansel, Beth
Project Start
1999-09-01
Project End
2003-08-31
Budget Start
2001-09-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2001
Total Cost
$181,089
Indirect Cost
Name
State University New York Stony Brook
Department
Neurology
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Strober, Lauren B; Christodoulou, Christopher; Benedict, Ralph H B et al. (2012) Unemployment in multiple sclerosis: the contribution of personality and disease. Mult Scler 18:647-53
Krupp, Lauren B; Benedict, Ralph H B (2010) Down a slippery slope: cognitive changes in pediatric MS. Neurology 75:1128-9
Chabas, D; Ness, J; Belman, A et al. (2010) Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology 74:399-405
Christodoulou, Christopher; MacAllister, William S; McLinskey, Nancy A et al. (2008) Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option? CNS Drugs 22:87-97
Christodoulou, Christopher; Melville, Patricia; Scherl, William F et al. (2006) Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 245:127-36
Christodoulou, Christopher; Melville, Patricia; Scherl, William F et al. (2005) Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis. J Int Neuropsychol Soc 11:614-9
Krupp, L B; Christodoulou, C; Melville, P et al. (2004) Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63:1579-85
Christodoulou, C; Krupp, L B; Liang, Z et al. (2003) Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 60:1793-8
Krupp, L B; Christodoulou, C (2001) Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep 1:294-8
Krupp, L B; Elkins, L E (2000) Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 55:934-9